• Skip to content
  • Skip to primary sidebar

Davis+Gilbert LLP

From our base in New York, we represent a diverse range of clients across the country and around the world.

  • People
  • Services
  • Emerging Issues

FDA

FTC and FDA Target Advertising of CBD Health Claims

May 17, 2019 by Megan O'Malley

The Bottom Line The legalization of hemp is a major step in establishing a potentially significant new industry. However, producers and marketers need to exercise caution when making health-related claims in connection with hemp-based product. The FTC and FDA will continue to aggressively review Continue Reading

Alert - May 17, 2019

FTC and FDA Sent Warning Letters to Companies Advertising Products that Claim Treatment of Disease

March 7, 2019 by Megan O'Malley

The Bottom Line The FTC and FDA are aggressively reviewing companies’ websites and social media channels for false or unsubstantiated health claims and efficacy claims. Advertisements on company websites and in social media posts must avoid false or unsubstantiated health claims, and efficacy Continue Reading

Alert - March 7, 2019

Regulatory and Class Action Claims Against “Healthy” and “Natural” Food and Dietary Supplement Products on the Rise

May 24, 2018 by Patrick Quinn

5th Edition: Trends in Marketing Communications Law The U.S. Food and Drug Administration (FDA) and class action bar are continuing to pursue enforcement and litigation against food and dietary supplement manufacturers who make drug claims, and in 2017, paid particular attention to products Continue Reading

Trends in Marketing Communications Law - May 24, 2018

FDA Withdraws Anti-Aging Import Alert and Continues Oversight Over Cosmetics Claims

May 24, 2018 by Patrick Quinn

5th Edition: Trends in Marketing Communications Law In late 2017, the U.S. Food and Drug Administration (FDA) officially withdrew Import Alert 66-38, "Skin Care Products Labeled as Anti-Aging Creams" (IA 66-38), potentially opening the doors for cosmetics manufacturers and marketers to make Continue Reading

Trends in Marketing Communications Law - May 24, 2018

FDA Continues Crackdown on Cosmetics Marketing Claims, and Microbead Ban Begins

April 11, 2017 by Patrick Quinn

4th Edition: Trends in Marketing Communications Law Regulating cosmetics continues to be an important priority for the Food and Drug Administration (FDA), although it remains to be seen whether the new administration will take a different approach. The FDA issued 30 warning letters to Continue Reading

Trends in Marketing Communications Law - April 11, 2017

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

  • Sitemap
  • Privacy Policy
  • Terms and Conditions
  • Accessibility Statement
  • About Us
  • Location
  • Subscribe
© 2025 Copyright Davis+Gilbert LLP. Attorney Advertising.
  • People
  • Services
  • Emerging Issues
  • Insights + Events
  • Culture + Community
  • Pro Bono + Corporate Social Responsibility
  • Careers
  • About Us
  • Subscribe
  • Location
This site uses cookies to store information on your device. These cookies either support essential functions of the site or are used to develop analytics regarding usage of our site. Click Accept to continue using the site with our recommended settings or click Decline to disable non-essential cookies.AcceptDecline